Volume 92, Issue 3, Pages (September 2017)

Slides:



Advertisements
Similar presentations
Silencing miR-106b accelerates osteogenesis of mesenchymal stem cells and rescues against glucocorticoid-induced osteoporosis by targeting BMP2  Ke Liu,
Advertisements

From: Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength
Volume 14, Issue 4, Pages (February 2016)
Peyman Hadji, Robert Coleman, Michael Gnant 
Volume 90, Issue 1, Pages (July 2016)
Volume 94, Issue 3, Pages (September 2018)
by Benjamin J. Frisch, John M. Ashton, Lianping Xing, Michael W
Volume 11, Issue 2, Pages (February 2010)
Volume 73, Issue 1, Pages 3-5 (January 2008)
Twist-related protein 1 negatively regulated osteoblastic transdifferentiation of human aortic valve interstitial cells by directly inhibiting runt-related.
Volume 93, Issue 1, Pages (January 2018)
Figure 4 Osteocyte regulation of bone formation and resorption
Yingben Xue, James C. Fleet  Gastroenterology 
Volume 88, Issue 4, Pages (October 2015)
M. Wang, H. Jin, D. Tang, S. Huang, M.J. Zuscik, D. Chen 
Volume 11, Issue 6, Pages (June 2010)
Volume 93, Issue 1, Pages (January 2018)
Volume 92, Issue 4, Pages (October 2017)
Volume 92, Issue 6, Pages (December 2017)
Volume 90, Issue 1, Pages (July 2016)
Steven C. Verberckmoes, Marc E. De Broe, Patrick C. D'Haese 
Volume 7, Issue 5, Pages (November 2010)
Volume 61, Issue 4, Pages (April 2002)
M. Wang, H. Jin, D. Tang, S. Huang, M.J. Zuscik, D. Chen 
Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate
Volume 19, Issue 6, Pages (June 2014)
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis
Volume 83, Issue 5, Pages (May 2013)
Exaggerated inflammatory environment decreases BMP-2/ACS-induced ectopic bone mass in a rat model: implications for clinical use of BMP-2  R.-L. Huang,
Volume 4, Issue 6, Pages (December 2006)
Volume 92, Issue 1, Pages (July 2017)
Volume 6, Issue 4, Pages (April 2016)
Volume 142, Issue 2, Pages (July 2010)
Thy-1/β3 Integrin Interaction-Induced Apoptosis of Dermal Fibroblasts Is Mediated by Up-Regulation of FasL Expression  Manuela Schmidt, Danny Gutknecht,
Volume 81, Issue 3, Pages (February 2012)
Volume 87, Issue 1, Pages (January 2015)
Volume 93, Issue 1, (January 2018)
Dysregulation of Chondrogenesis in Human Cleidocranial Dysplasia
Volume 16, Issue 3, Pages (July 2016)
Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament.
Volume 130, Issue 5, Pages (September 2007)
Volume 5, Issue 6, Pages (June 2007)
Volume 80, Issue 12, Pages (December 2011)
Smurf1 Inhibits Osteoblast Differentiation, Bone Formation, and Glucose Homeostasis through Serine 148  Junko Shimazu, Jianwen Wei, Gerard Karsenty  Cell.
Volume 85, Issue 1, Pages (January 2014)
Volume 13, Issue 6, Pages (November 2015)
Volume 11, Issue 3, Pages (March 2010)
Volume 24, Issue 2, Pages (February 2016)
Volume 11, Issue 6, Pages (June 2010)
Promotion Effects of miR-375 on the Osteogenic Differentiation of Human Adipose- Derived Mesenchymal Stem Cells  Si Chen, Yunfei Zheng, Shan Zhang, Lingfei.
Volume 92, Issue 3, Pages (September 2017)
Bone-Targeted Alkaline Phosphatase Treatment of Mandibular Bone and Teeth in Lethal Hypophosphatasia via an scAAV8 Vector  Ryo Ikeue, Aki Nakamura-Takahashi,
Volume 14, Issue 5, Pages (May 2008)
Volume 95, Issue 5, Pages (May 2019)
Volume 8, Issue 2, Pages (August 2008)
Neil J. Paloian, Elizabeth M. Leaf, Cecilia M. Giachelli 
Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy  Carolina Lavoz, Yenniffer Sánchez Matus,
Volume 84, Issue 4, Pages (October 2013)
Volume 92, Issue 4, (October 2017)
Volume 85, Issue 6, Pages (June 2014)
Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice by M. Neale Weitzmann, Susanne Roser-Page,
EBF2 Regulates Osteoblast-Dependent Differentiation of Osteoclasts
Volume 82, Issue 10, Pages (November 2012)
Volume 74, Issue 5, Pages (September 2008)
mTOR Inhibition Subdues Milk Disorder Caused by Maternal VLDLR Loss
Molecular Therapy - Nucleic Acids
Volume 95, Issue 5, Pages (May 2019)
Volume 14, Issue 4, Pages (February 2016)
Volume 11, Pages (January 2019)
Volume 8, Issue 6, Pages (June 2017)
Presentation transcript:

Volume 92, Issue 3, Pages 599-611 (September 2017) Klotho expression in osteocytes regulates bone metabolism and controls bone formation  Hirotaka Komaba, Jovana Kaludjerovic, Dorothy Z. Hu, Kenichi Nagano, Katsuhiko Amano, Noriko Ide, Tadatoshi Sato, Michael J. Densmore, Jun-ichi Hanai, Hannes Olauson, Teresita Bellido, Tobias E. Larsson, Roland Baron, Beate Lanske  Kidney International  Volume 92, Issue 3, Pages 599-611 (September 2017) DOI: 10.1016/j.kint.2017.02.014 Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 1 Generation of mice with osteocyte-specific Klotho deletion and tdTomato expression. (a) Schematic representation of wild-type (WT) allele (top) and floxed Klotho allele before (middle) and after Cre-mediated deletion (bottom). (b) Schematic representation of floxed STOP tdTomato allele before (top) and after Cre-mediated recombination (bottom). (c) Localization of tdTomato fluorescence in frozen sections from 5-week-old control mice (Dmp1-tdTomato). tdTomato is expressed at high levels in osteocytes and is also present in the kidney medulla but is not expressed in the renal proximal and distal tubular cells and parathyroid cells (arrowheads). Bar = 300 μm. (d) Immunohistochemical staining of Klotho in tibial cortical bone and kidney from control mice and Dmp1-Klotho−/− mice: arrowheads indicate positive Klotho staining in osteocytes. Bar = 100 μm. (e) Quantitative real-time polymerase chain reaction analysis of Klotho transcript in the femur, calvarium, and kidney from control mice and Dmp1-Klotho−/− mice. Data are represented as mean ± SD; *P < 0.05 by t test, n = 5–7 in each group. (f) Immunofluorescence staining of Klotho in osteocytes isolated from the long bones of control mice and Dmp1-Klotho−/− mice. Bar = 20 μm (also refer Figure S1). DAPI, 4′,6-diamidino-2-phenylindole; GAPDH, glyceraldehyde-3-phosphate dehydrogenase. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2017 92, 599-611DOI: (10.1016/j.kint.2017.02.014) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 2 Osteocyte-specific deletion of Klotho increases bone formation and bone mass. (a) von Kossa staining of distal femur sections from 5-week-old control mice and Dmp1-Klotho−/− mice. Bar = 500 μm. (b) Histomorphometric analysis of tibiae from control mice and Dmp1-Klotho−/− mice. Data are represented as mean ± SD; *P < 0.05 by t test, n = 6 in each group. (c) Serum N-terminal propeptide of type I procollagen (PINP) and C-terminal telopeptide fragments of the type I collagen (CTX) in control mice and Dmp1-Klotho−/− mice. Data are represented as mean ± SD; *P < 0.05 by t test, n = 7 in each group. (d) Quantitative real-time polymerase chain reaction analysis of bone metabolism-related genes in femur from control mice and Dmp1-Klotho−/− mice. Data are represented as mean ± SD; *P < 0.05 by t test, n = 7 in each group. ALP, alkaline phosphatase; BFR/BS, bone formation rate; BV/TV, bone volume fraction; Col1a1, collagen type 1; Dkk1, Dickkopf-1; FGF23, fibroblast growth factor 23; MAR, mineral apposition rate; MCSF, macrophage colony-stimulating factor; MS/BS, mineralizing surface; Ob.S/BS, osteoblast surface; OCN, osteocalcin; Oc.S/BS, osteoclast surface; OPN, osteopontin; RANKL/OPG, receptor activator of nuclear factor-kappaB ligand-osteoprotegerin; Runx2, runt-domain transcription factor 2; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2017 92, 599-611DOI: (10.1016/j.kint.2017.02.014) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 3 Klotho overexpression inhibits mineralization and osteogenic activity in MC3T3.E1 cells during osteocyte differentiation. (a) Alizarin red staining of differentiated MC3T3.E1 cells with lentivirus-mediated overexpression of green fluorescent protein (GFP) or Klotho. (b) Quantification of Alizarin red staining. Data are represented as mean ± SD; *P < 0.05 by t test, n = 6 in each group. (c) Quantitative real-time polymerase chain reaction analysis of bone metabolism-related genes in differentiated MC3T3.E1 cells overexpressing GFP or Klotho. Data are represented as mean ± SD; *P < 0.05 by t test, n = 6 in each group. ALP, alkaline phosphatase; Col1a1, collagen type 1; FGF23, fibroblast growth factor 23; LV, lentivirus; OCN, osteocalcin; OPN, osteopontin; Runx2, runt-domain transcription factor 2. To optimize viewing of this image, please see the online version of this article at www.kidney-international.org. Kidney International 2017 92, 599-611DOI: (10.1016/j.kint.2017.02.014) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 4 Quantitative real-time polymerase chain reaction analysis of renal transcripts from control mice and Dmp1-Klotho−/− mice with sham operation or 5/6 nephrectomy (NTx) under normal or high-phosphate diet (HPD) feeding. Data are represented as mean ± SD; P values are from 2-way analysis of variance, n = 8 in each group. FGFR1, fibroblast growth factor receptor 1. Kidney International 2017 92, 599-611DOI: (10.1016/j.kint.2017.02.014) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 5 Skeletal effect of osteocyte-specific Klotho deletion is attenuated in a model of high-turnover renal osteodystrophy. (a) Histomorphometric analysis of tibiae from control mice and Dmp1-Klotho−/− mice with sham operation or 5/6 nephrectomy (NTx) under normal or high-phosphate diet (HPD) feeding. Data are represented as mean ± SD; P values are from 2-way analysis of variance (ANOVA), n = 6 in each group. (b) Serum N-terminal propeptide of type I procollagen (PINP) and C-terminal telopeptide fragments of the type I collagen (CTX) in control mice and Dmp1-Klotho−/− mice with sham operation or NTx under normal or HPD feeding. Data are represented as mean ± SD; P values are from 2-way ANOVA, n = 8 in each group. BFR/BS, bone formation rate; BV/TV, bone volume fraction; MAR, mineral apposition rate; MS/BS, mineralizing surface; N.Ot/B.Ar, number of osteoblast per bone area; Ob.S/BS, osteoblast surface; Oc.S/BS, osteoclast surface; OS/BS, osteoid surface; Tb.N, trabecular number; Tb.Sp, trabecular separation; Tb.Th, trabecular thickness. Kidney International 2017 92, 599-611DOI: (10.1016/j.kint.2017.02.014) Copyright © 2017 International Society of Nephrology Terms and Conditions

Figure 6 Quantitative real-time polymerase chain reaction analysis of bone metabolism-related genes in femurs from control mice and Dmp1-Klotho−/− mice with sham operation or 5/6 nephrectomy (NTx) under normal or high-phosphate diet (HPD) feeding. Data are represented as mean ± SD; P values are from 2-way analysis of variance, n = 6–8 in each group. ALP, alkaline phosphatase; Col1a1, collagen type 1; FGF23, fibroblast growth factor 23; FGFR1, fibroblast growth factor receptor 1; OCN, osteocalcin; OPN, osteopontin; MCSF, macrophage colony-stimulating factor; RANKL/OPG, receptor activator of nuclear factor-kappaB ligand-osteoprotegerin; Runx2, runt-domain transcription factor 2. Kidney International 2017 92, 599-611DOI: (10.1016/j.kint.2017.02.014) Copyright © 2017 International Society of Nephrology Terms and Conditions